Suppression of Bcl-xL gene through co-delivery of Doxorubicin and small hairpin RNA (shRNA) in polyplexes conjugated with an anti-PSMA aptamer specifically binds the prostate-specific membrane antigen expressed on prostate cancer cell surface. This evidence concerns the gene FOLH1 and Familial prostate cancer.